Advent strikes €4.1bn deal to sell generic drugmaker Zentiva to GTCR
Sale is second private equity-backed healthcare transaction within weeks in Europe
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Zentiva
since
auto-detected in 1 stories
88 days ago
page 1 of 1